Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Press Release dsm-firmenich announces share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), March 12, 2026 dsm-firmenich, innovators...
-
Press releaseCommuniqué de pressePersbericht Regulated Participation notifications by BlackRock Inc. Brussels, Belgium - March 11, 2026 – 17:45 CET According to Belgian transparency legislation...
-
Ålandsbanken AbpBörsmeddelande - Totalt antal rösträtter och kapital11.3.2026 kl. 12.30 EET Ålandsbanken Abp: Riktad emission inom ramen för ersättningssystem för rörliga ersättningar till...
-
Bank of Åland PlcStock Exchange Release - Total number of voting rights and capital11 March 2026, 12.30 EET Bank of Åland plc: Directed share issue for implementation of the variable compensation...
-
Information mensuelle relative au nombre total d’actions et de droits de vote de Quadient S.A. Etabli en application de l’article 223.11 du Règlement Général de l’Autorité des Marchés Financiers ...
-
Monthly information on number of shares and voting rights of Quadient S.A. In accordance with article 223.11 of Autorité des Marchés Financiers’ (French Securities and Investment board) General...
-
OKOTOKS, Alberta, March 09, 2026 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. ("Mullen Group" and/or the "Corporation") announced today that it has received approval from the Toronto Stock...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 06, 2026 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp....
-
VANCOUVER, British Columbia, March 06, 2026 (GLOBE NEWSWIRE) -- Canfor Pulp Products Inc. (TSX: CFX) (“Canfor Pulp” or the “Company”) is pleased to announce that at the special meeting (the “Company...
-
NAARDEN, the Netherlands and MIAMI, March 06, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...